Globe Residency REIT's Steady Performance in 1H 2024: A Deeper Dive

The Pakistan Stock Exchange has released the latest data on Globe Residency REIT, showcasing its steady performance in the first half of 2024. As of October 23, the share rate stands at Rs. 13.65 with a daily weighted average rate of Rs. 13.70. With a paid-up capital of Rs. 1.40 billion, the company has maintained a steady presence in the real estate investment sector since its listing in 2022.

Key Takeaways:

  • Globe Residency REIT's share rate as of October 23, 2024, is Rs. 13.65, with a daily weighted average rate of Rs. 13.70.
  • The company has a paid-up capital of Rs. 1.40 billion and was listed in 2022.
  • The performance in distributions shows a decline over the past three years, from 30% in 2022 to 17.50% in 2023 and projected to decrease to 10% for 2024.
  • The high and low share rates from January to June 2024 were recorded at Rs. 15.10 and Rs. 11.87, respectively.
  • The previous book closure was on September 21, which indicates crucial timelines for dividend payments and other rights for shareholders.
  • The company's performance in 1H 2024 is crucial for investors making informed decisions in the real estate investment trust market.
  • Globe Residency REIT's financial trajectory and market behavior are vital for investors, highlighting the need for a deeper understanding of the company's performance.

Statistics:

  • Share rate as of October 23, 2024: Rs. 13.65
  • Daily weighted average rate as of October 23, 2024: Rs. 13.70
  • Paid-up capital: Rs. 1.40 billion
  • Listing year: 2022
  • Market lot: 1 share
  • Par value per share: Rs. 10
  • Distribution percentage for 2022: 30%
  • Distribution percentage for 2023: 17.50%
  • Projected distribution percentage for 2024: 10%
  • High share rate from January to June 2024: Rs. 15.10
  • Low share rate from January to June 2024: Rs. 11.87
  • Book closure date: September 21, 2024

Sources:

  • Pakistan Stock Exchange (PSX)
  • Globe Residency REIT's official listing documents